6533b859fe1ef96bd12b78a4

RESEARCH PRODUCT

Translating Inflammatory Bowel Disease Research into Clinical Medicine

Markus F. NeurathSusetta Finotto

subject

CD4-Positive T-Lymphocytesmedicine.medical_specialtyImmunologyAnti-Inflammatory AgentsIndividualized treatmentTranslational researchGastroenterologyInflammatory bowel diseasePathogenesisBasic researchInternal medicineDrug DiscoverymedicineAnimalsHumansImmunology and AllergyIntensive care medicineMononuclear Phagocyte Systembusiness.industryInterleukinsmedicine.diseaseInflammatory Bowel Diseasesdigestive system diseasesDisease Models AnimalInfectious Diseasesbusiness

description

Recent studies have provided important insights into the pathogenesis of inflammatory bowel disease (IBD). The development of new therapeutic agents has been triggered by basic research and studies in mouse models of IBD. It is expected that improved translational research will lead to optimized therapy and new individualized treatment options.

yearjournalcountryeditionlanguage
2009-09-01Immunity
10.1016/j.immuni.2009.08.016http://dx.doi.org/10.1016/j.immuni.2009.08.016